Papular urticaria.

A S Stibich; R A Schwartz

Home/Archive/PubMed

PubMed · 11534921

Papular urticaria.

A S Stibich·R A Schwartz

View original source ↗Export metadata ↓

Abstract

Papular urticaria is a common and often distressing childhood disorder manifested by chronic or recurrent papules caused by a hypersensitivity reaction to the bites of mosquitoes, fleas, bedbugs, and other insects. Individual papules may surround a wheal and often have a central punctum. The histopathology of papular urticaria consists of mild subepidermal edema, extravasation of erythrocytes, interstitial eosinophils, and exocytosis of lymphocytes. Papular urticaria may represent a clinical challenge, particularly during spring and summer months.

Explore related subjects

Age Distribution Child Child, Preschool Female Humans Hypersensitivity Incidence Male Prognosis Risk Factors Seasons Skin Diseases, Vesiculobullous Urticaria Journal Article Review

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

A S Stibich, R A Schwartz. 2001. Papular urticaria.. https://pubmed.ncbi.nlm.nih.gov/11534921/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2002

Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention.

CONTEXT: A higher mortality risk for women with acute myocardial infarction (AMI) is a common finding in studies that compare the postinfarction outcome of women vs men. It is not clear, however, whether sex is an independent predictor of death among patients systematically treated with aggressive reperfusion and medical strategies. OBJECTIVE: To assess the impact of patient's sex on outcome in a consecutive series of patients with AMI treated with a reperfusion strategy largely based on percutaneous coronary interventions. DESIGN, SETTING, AND PATIENTS: Inception cohort of 1937 patients (502 women and 1435 men) who were admitted with a diagnosis of AMI to a tertiary referral institution between January 1995 and December 2000. MAIN OUTCOME MEASURES: Mortality at 1 year after AMI. RESULTS: Compared with men, women were older (70 vs 61 years; P<.001) and had known diabetes or hypertension more often. Both men and women received essentially identical therapy with the majority of patients (86%) receiving reperfusion therapy via percutaneous coronary interventions. There were no significant differences in 1-year Kaplan-Meier death rates with 13.8% (68 cases) among women and 12.9% (184 cases) among men (unadjusted hazard ratio, 1.06; 95% confidence interval, 0.80-1.39; P =.70). After age adjustment, women had a lower risk of death (hazard ratio, 0.65; 95% confidence interval, 0.49-0.87; P =.004). CONCLUSION: Despite their more advanced age and greater prevalence of diabetes or hypertension, women with AMI who were treated with a reperfusion strategy largely based on percutaneous coronary interventions show a similar outcome as men.

Age Distribution↗

PubMed2002

Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.

Explore the source record for details and available documents.

Age Distribution↗

PubMed2002

Ampicillin use in infant fever: a systematic review.

OBJECTIVES: To estimate the prevalence of perinatal Listeria monocytogenes and enterococcal infections in outpatient febrile infants and to evaluate the need to treat with ampicillin. DATA SOURCES: Online bibliographies were searched for articles related to serious bacterial infection and fever in infants. Reference lists from selected and review articles were also examined. STUDY SELECTION: Studies that reported rates and types of bacterial infection in febrile outpatients younger than 3 months were included. Those performed outside North America, lacking results by age, or those that evaluated selected patient populations were excluded. DATA EXTRACTION: Two authors independently reviewed the selected articles for inclusion and abstracted the data. DATA SYNTHESIS: Fourteen studies, evaluating 5247 febrile outpatients, were included. The prevalences of L monocytogenes and enterococcal infections were 7.3 (binomial exact 95% confidence interval [CI], 3.5-13.3), 1.9 (95% CI, 0.6-4.4), and 5.6 (95% CI, 0.7-2.1) per 1000 febrile infants in the first, second, and third months of life, respectively. To cover 1 infant with serious bacterial infection caused by L monocytogenes and enterococcal infections, the numbers of febrile infants who would need ampicillin were estimated as 138 (95% CI, 76-288) in the first month, 527 (95% CI, 226-1621) in the second month, and 178 (95% CI, 50-1469) in the third month. Enterococcal infections occurred in all ages studied; there were no Listeria infections after 30 days of age. CONCLUSION: The empirical use of ampicillin to cover febrile infants for L monocytogenes and enterococcal infections is most justifiable in the first month of life.

Age Distribution↗